Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ ABCB9 Monoclonal Antibody (4F4)
Mouse Monoclonal Antibody
Supplier: Invitrogen™ MA521478
Description
Peptide Sequence: FIDRQPTMVH DGSLAPDHLE GRVDFENVTF TYRTRPHTQV LQNVSFSLSP GKVTALVGPS GSGKSSCVNI LENFYPLEGG RVLLDGKPIS AYDHKYLHR.
The structure specific ERCC 1 / XPF endonuclease complex is implicated in the repair of two distinct types of lesions in DNA: NER for UV induced lesions and bulky chemical adducts; and recombination repair of the very genotoxic interstrand cross links. NER mechanism involves dual incisions on both sides of the damage catalyzed by two nucleases. In mammalian cells, XPG cleaves 3' of the DNA lesion while the ERCC1 / XPF complex makes the 5' incision. ERCC1 / XPF probably plays a role in processing partially processed recombination intermediates.
Specifications
ABCB9 | |
Monoclonal | |
1.0 mg/mL | |
PBS with no preservative; pH 7.4 | |
Q9NP78 | |
ABCB9 | |
ABCB9 (NP_062571, 482 a.a. ~ 580 a.a) partial recombinant protein with GST tag. MW of the GST tag alone is 26 KDa. | |
100 μg | |
Primary | |
Human | |
Antibody | |
IgG2b κ |
ELISA, Western Blot, Immunocytochemistry | |
4F4 | |
Unconjugated | |
ABCB9 | |
ABC transporter 9 protein; ABCB9; ATP binding cassette subfamily B member 9; ATP-binding cassette sub-family B member 9; ATP-binding cassette transporter 9; ATP-binding cassette, subfamily B (MDR/TAP), member 9; ATP-binding cassette, sub-family B (MDR/TAP), member 9; ATP-binding cassette, sub-family B, member 9; EST122234; KIAA1520; LOW QUALITY PROTEIN: ATP-binding cassette sub-family B member 9; mABCB9; mKIAA1520; TAPL; TAP-like ABC transporter; TAP-like protein | |
Mouse | |
Affinity chromatography | |
RUO | |
23457 | |
-20°C, Avoid Freeze/Thaw Cycles | |
Liquid |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction